CD8A and neoplasm: The major role of CD8 T cells in tumor inhibition has been established in tumor treated with CD8-depleting antibodies where the tumor was unable to induce resistance to tumor rechallenged, thus indicating that CD8+ T cells are required for treatment efficacy12.